
1. Antimicrob Agents Chemother. 2011 May;55(5):2472-4. doi: 10.1128/AAC.01466-10.
Epub 2011 Feb 22.

In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains 
resistant to standard antimalarial drugs.

Pascual A(1), Henry M, Briolant S, Charras S, Baret E, Amalvict R, Huyghues des
Etages E, Feraud M, Rogier C, Pradines B.

Author information: 
(1)Unité de Parasitologie, Institut de Recherche Biomédicale des Armées-Antenne
de Marseille, Allée du Médecin-Colonel Jamot, Parc le Pharo, BP 60109, 13262
Marseille Cedex 7, France.

The geometric mean 50% inhibitory concentration (IC50) for Proveblue, a methylene
blue complying with the European Pharmacopoeia, was more active on 23 P.
falciparum strains than chloroquine, quinine, mefloquine,
monodesethylamodiaquine, and lumefantrine. We did not find significant
associations between the Proveblue IC50 and polymorphisms in the pfcrt, pfmdr1,
pfmdr2, pfmrp, and pfnhe-1 genes or the copy numbers of the pfmdr1 and pfmdr2
genes, all of which are involved in antimalarial resistance.

DOI: 10.1128/AAC.01466-10 
PMCID: PMC3088279
PMID: 21343466  [Indexed for MEDLINE]

